Final report of the phase II NEXT/CNS-GCT-4 trial: GemPOx followed by marrow-ablative chemotherapy for recurrent intracranial germ cell tumors.
Margaret ShataraMegan BlueJoseph R StanekYin A LiuDaniel M PrevedelloPierre GiglioVinay K PuduvalliSharon L GardnerJeffrey C AllenKenneth K WongMarvin D NelsonFloyd H GillesRoberta H AdamsJasmine PaulyKatrina O'HalloranAshley S MargolGirish DhallJonathan L FinlayPublished in: Neuro-oncology practice (2023)
GemPOx demonstrates efficacy in facilitating stem cell mobilization, thus facilitating the feasibility of both HDCx and radiotherapy.